Global Metagenomic Sequencing Market to Reach $3.2 Billion by 2027
Abstract: - Global Metagenomic Sequencing Market to Reach $3. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Metagenomic Sequencing estimated at US$1.
New York, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Metagenomic Sequencing Industry" - https://www.reportlinker.com/p06032179/?utm_source=GNW
1 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 15.9% over the analysis period 2020-2027. Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 16.7% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 15.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $306.8 Million, While China is Forecast to Grow at 20.6% CAGR
- The Metagenomic Sequencing market in the U.S. is estimated at US$306.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$742.4 Million by the year 2027 trailing a CAGR of 20.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.3% and 14% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.
- Services Segment to Record 15.2% CAGR
- In the global Services segment, USA, Canada, Japan, China and Europe will drive the 14.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$169.4 Million in the year 2020 will reach a projected size of US$430.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$492 Million by the year 2027, while Latin America will expand at a 16.9% CAGR through the analysis period.
- Select Competitors (Total 35 Featured) -
BGI Group
DNAStar, Inc.
Eurofins Scientific
GENEWIZ
Illumina, Inc.
IntegraGen SA
Macrogen, Inc.
Microsynth AG
Novogene Corporation
NuGEN Technologies, Inc.
Oxford Nanopore Technologies Ltd.
PerkinElmer
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
Zymo Research Corporation
Read the full report: https://www.reportlinker.com/p06032179/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Metagenomic
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Metagenomic Sequencing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Metagenomic Sequencing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Reagents &
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Reagents & Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Reagents & Consumables
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Analysis & Data
Interpretation Solutions by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Analysis & Data
Interpretation Solutions by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Analysis & Data
Interpretation Solutions by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
Table 16: World Current & Future Analysis for Clinical
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Clinical Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Clinical Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Soil Microbiome
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 20: World Historic Review for Soil Microbiome by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for Soil Microbiome by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Industrial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 23: World Historic Review for Industrial by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 24: World 15-Year Perspective for Industrial by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 25: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 26: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 28: World Current & Future Analysis for Drug Discovery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 29: World Historic Review for Drug Discovery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Drug Discovery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 31: World Current & Future Analysis for Shotgun by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 32: World Historic Review for Shotgun by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 33: World 15-Year Perspective for Shotgun by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 34: World Current & Future Analysis for 16S rRNA by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 35: World Historic Review for 16S rRNA by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 36: World 15-Year Perspective for 16S rRNA by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027
Table 37: World Current & Future Analysis for
Metatranscriptomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 38: World Historic Review for Metatranscriptomics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 39: World 15-Year Perspective for Metatranscriptomics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027
Table 40: World Current & Future Analysis for Whole-Genome
Sequencing & De Novo Assembly by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 41: World Historic Review for Whole-Genome Sequencing &
De Novo Assembly by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 42: World 15-Year Perspective for Whole-Genome Sequencing &
De Novo Assembly by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 43: USA Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 44: USA Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 45: USA 15-Year Perspective for Metagenomic Sequencing by
Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 46: USA Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 47: USA Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 48: USA 15-Year Perspective for Metagenomic Sequencing by
Application - Percentage Breakdown of Value Sales for Clinical
Diagnostics, Soil Microbiome, Industrial, Other Applications
and Drug Discovery for the Years 2012, 2020 & 2027
Table 49: USA Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 50: USA Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 51: USA 15-Year Perspective for Metagenomic Sequencing by
Technology - Percentage Breakdown of Value Sales for Shotgun,
16S rRNA, Metatranscriptomics and Whole-Genome Sequencing & De
Novo Assembly for the Years 2012, 2020 & 2027
CANADA
Table 52: Canada Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 53: Canada Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 54: Canada 15-Year Perspective for Metagenomic Sequencing
by Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 55: Canada Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 56: Canada Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 57: Canada 15-Year Perspective for Metagenomic Sequencing
by Application - Percentage Breakdown of Value Sales for
Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 58: Canada Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 59: Canada Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 60: Canada 15-Year Perspective for Metagenomic Sequencing
by Technology - Percentage Breakdown of Value Sales for
Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
JAPAN
Table 61: Japan Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 62: Japan Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 63: Japan 15-Year Perspective for Metagenomic Sequencing
by Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 64: Japan Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 65: Japan Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 66: Japan 15-Year Perspective for Metagenomic Sequencing
by Application - Percentage Breakdown of Value Sales for
Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 67: Japan Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 68: Japan Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 69: Japan 15-Year Perspective for Metagenomic Sequencing
by Technology - Percentage Breakdown of Value Sales for
Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
CHINA
Table 70: China Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 71: China Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 72: China 15-Year Perspective for Metagenomic Sequencing
by Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 73: China Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 74: China Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 75: China 15-Year Perspective for Metagenomic Sequencing
by Application - Percentage Breakdown of Value Sales for
Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 76: China Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 77: China Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 78: China 15-Year Perspective for Metagenomic Sequencing
by Technology - Percentage Breakdown of Value Sales for
Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
EUROPE
Table 79: Europe Current & Future Analysis for Metagenomic
Sequencing by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 80: Europe Historic Review for Metagenomic Sequencing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 81: Europe 15-Year Perspective for Metagenomic Sequencing
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 82: Europe Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 83: Europe Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 84: Europe 15-Year Perspective for Metagenomic Sequencing
by Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 85: Europe Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 86: Europe Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 87: Europe 15-Year Perspective for Metagenomic Sequencing
by Application - Percentage Breakdown of Value Sales for
Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 88: Europe Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 89: Europe Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 90: Europe 15-Year Perspective for Metagenomic Sequencing
by Technology - Percentage Breakdown of Value Sales for
Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
FRANCE
Table 91: France Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 92: France Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 93: France 15-Year Perspective for Metagenomic Sequencing
by Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 94: France Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 95: France Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 96: France 15-Year Perspective for Metagenomic Sequencing
by Application - Percentage Breakdown of Value Sales for
Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 97: France Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 98: France Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 99: France 15-Year Perspective for Metagenomic Sequencing
by Technology - Percentage Breakdown of Value Sales for
Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
GERMANY
Table 100: Germany Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 101: Germany Historic Review for Metagenomic Sequencing
by Component - Reagents & Consumables, Instruments, Services
and Analysis & Data Interpretation Solutions Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 102: Germany 15-Year Perspective for Metagenomic
Sequencing by Component - Percentage Breakdown of Value Sales
for Reagents & Consumables, Instruments, Services and Analysis &
Data Interpretation Solutions for the Years 2012, 2020 & 2027
Table 103: Germany Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 104: Germany Historic Review for Metagenomic Sequencing
by Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 105: Germany 15-Year Perspective for Metagenomic
Sequencing by Application - Percentage Breakdown of Value Sales
for Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 106: Germany Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 107: Germany Historic Review for Metagenomic Sequencing
by Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 108: Germany 15-Year Perspective for Metagenomic
Sequencing by Technology - Percentage Breakdown of Value Sales
for Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
ITALY
Table 109: Italy Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 110: Italy Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 111: Italy 15-Year Perspective for Metagenomic Sequencing
by Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Table 112: Italy Current & Future Analysis for Metagenomic
Sequencing by Application - Clinical Diagnostics, Soil
Microbiome, Industrial, Other Applications and Drug Discovery -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 113: Italy Historic Review for Metagenomic Sequencing by
Application - Clinical Diagnostics, Soil Microbiome,
Industrial, Other Applications and Drug Discovery Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 114: Italy 15-Year Perspective for Metagenomic Sequencing
by Application - Percentage Breakdown of Value Sales for
Clinical Diagnostics, Soil Microbiome, Industrial, Other
Applications and Drug Discovery for the Years 2012, 2020 & 2027
Table 115: Italy Current & Future Analysis for Metagenomic
Sequencing by Technology - Shotgun, 16S rRNA,
Metatranscriptomics and Whole-Genome Sequencing & De Novo
Assembly - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 116: Italy Historic Review for Metagenomic Sequencing by
Technology - Shotgun, 16S rRNA, Metatranscriptomics and
Whole-Genome Sequencing & De Novo Assembly Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 117: Italy 15-Year Perspective for Metagenomic Sequencing
by Technology - Percentage Breakdown of Value Sales for
Shotgun, 16S rRNA, Metatranscriptomics and Whole-Genome
Sequencing & De Novo Assembly for the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 118: UK Current & Future Analysis for Metagenomic
Sequencing by Component - Reagents & Consumables, Instruments,
Services and Analysis & Data Interpretation Solutions -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 119: UK Historic Review for Metagenomic Sequencing by
Component - Reagents & Consumables, Instruments, Services and
Analysis & Data Interpretation Solutions Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 120: UK 15-Year Perspective for Metagenomic Sequencing by
Component - Percentage Breakdown of Value Sales for Reagents &
Consumables, Instruments, Services and Analysis & Data
Interpretation Solutions for the Years 2012, 2020 & 2027
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032179/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
